Disease | vascular disease |
Phenotype | C0242350|erectile dysfunction |
Sentences | 10 |
PubMedID- 21711956 | What are the effects of phosphodiesterase inhibitors on erectile dysfunction in men with diabetes, with cardiovascular disease, with spinal cord injury, and with prostate cancer or undergoing prostatectomy. |
PubMedID- 23678264 | erectile dysfunction is associated with cardiovascular disease risk factors such as smoking, hypercholesterolemia, and diabetes (1, 2). |
PubMedID- 21699670 | Introduction: erectile dysfunction (ed) is associated with cardiovascular disease (cvd) because it is highly prevalent among those with cardiovascular risk factors (cvrfs). |
PubMedID- 24386867 | [tadalafil for erectile dysfunction associated with cardiovascular diseases]. |
PubMedID- 21323898 | Background and purpose: erectile dysfunction correlates with cardiovascular disease and its common risk factors due to the development of endothelial dysfunction. |
PubMedID- 25677231 | This review outlines the proper technique for pdu and the literature supporting the use of pdu to predict cardiovascular disease in men with erectile dysfunction. |
PubMedID- 20963365 | Context and objective: erectile dysfunction has been associated with cardiovascular diseases. |
PubMedID- 25293632 | Introduction: erectile dysfunction (ed) is associated with cardiovascular disease (cvd); however, the association between change in ed status over time and future underlying cvd risk is unclear. |
PubMedID- 22101885 | Prevalence of risk factors of cardiovascular diseases in men with erectile dysfunction. |
PubMedID- 25462324 | Rates of erectile dysfunction among men with cardiovascular disease (cvd) are twice as high as those in the general population with similar rates of sexual dysfunction in females with cvd. |
Page: 1